Skip to main content
. Author manuscript; available in PMC: 2009 Feb 3.
Published in final edited form as: J Neuropathol Exp Neurol. 2008 Apr;67(4):271–279. doi: 10.1097/NEN.0b013e31816a12a6

TABLE 1.

Numbers of cases in each diagnostic category before and after TDP-43 immunohistochemistry, mean age at death, and progranulin mutation status

n Mean age (± SEM) PGRN Mutations (+/−)
FTLD-U 68 -> 67 66 ± 1.5 14/35
FTLD-U, non-TDP-43 0 -> 4 57 ± 4.5 0/2
FTLD-U with VCP mut. 2 -> 2 54 ± 6.5 0/2
DLDH 4 -> 1 98 0/1
Other neurodegen. 23 -> 23 74 ± 2.5 0/5
Controls 12 -> 12 77 ± 2.7 0/2

PGRN, progranulin; FTLD-U, frontotemporal lobar degeneration with ubiquitinated inclusions; VCP mut., mutations in valosin-containing protein; DLDH, dementia lacking distinctive histopathology; neurodegen., neurodegenerative diseases